STARTING IBSRELA
Here are a few things to keep in mind, to help you get started on IBSRELA.
Let’s do this...
Man and woman driving on the beach Man and woman driving on the beach

How to take IBSRELA

IBSRELA is a 50 mg tablet that is taken twice a day, just before breakfast and just before dinner.
IBSRELA morning dose
IBSRELA evening dose
IBSRELA prescription bottle and pill
Things to keep in mind when taking IBSRELA:
    • If you miss a dose, skip the missed dose, and take the next dose at the regular time
    • Do not take 2 doses of IBSRELA at the same time
    • Talk to your healthcare provider if you have questions about taking IBSRELA

$0 * Pay as little as $0 for IBSRELA

Eligible patients with commercial insurance pay as little as $0* per 30-day prescription fill of IBSRELA. The discount will be automatically applied for eligible patients at the majority of pharmacies.

*Program Disclosure: The Copay Assistance Program is available to patients only for “on-label” use. Please see additional terms and conditions for further eligibility requirements.


Ardelyx Assist logo
 
Call us at 844-427-7352, option 1

if you have any questions or need support with IBSRELA access or affordability.

Man looking at cellphone
IBSRELA retention patient brochure
IBSRELA retention patient brochure

Welcome to IBSRELA

Starting IBSRELA? Here are some key things to know

Susan Wolgamott, DNP

THE IBS-CONNECTION

The Importance of Shared Decision-Making

Susan, a nurse practitioner, works closely with her patients to keep them informed about different medications, because she knows there is no one-size-fits-all approach to treating IBS‑C.

Watch the full video.

Susan is a compensated advisor to Ardelyx.

View transcript

ON SCREEN/SUPER: Susan Wolgamott, DNP
Susan is a compensated advisor to Ardelyx

Susan VO:

Because there are many potential underlying causes of IBS‑C, there is no one-size-fits-all treatment approach.

That’s why I let my patients know that we have different medications to treat IBS‑C, which is good because there are many underlying causes for this condition, and classes of drugs work differently for different people.

I also talk to my patients about the importance of having good two-way communication between us. There will be a lot of trial and error to find the right medication for each patient, but with a collaborative, joint decision-making process, we will work together to find the treatment that is right for them.

IMPORTANT RISK INFORMATION

  • Do not give IBSRELA to children who are less than 6 years of age. It may harm them.
  • You should not give IBSRELA to patients 6 years to less than 18 years of age. It may harm them. IBSRELA can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).
  • Do not take IBSRELA if a doctor has told you that you have a bowel blockage (intestinal obstruction).

Before you take IBSRELA, tell your doctor about your medical conditions, including if you are:

  • Pregnant or plan to become pregnant. It is not known if IBSRELA will harm your unborn baby.
  • Breastfeeding or plan to breastfeed. It is not known if IBSRELA passes into your breast milk. Talk with your doctor about the best way to feed your baby if you take IBSRELA.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.

Side Effects

Diarrhea is the most common side effect of IBSRELA, and it can sometimes be severe. Stop taking IBSRELA and call your doctor if you develop severe diarrhea.

Other common side effects of IBSRELA include swelling, or a feeling of fullness or pressure in your abdomen (distension), gas (flatulence), or dizziness.

These are not all the possible side effects of IBSRELA. Call your doctor for medical advice about side effects.

You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to www.fda.gov/medwatch.

What is IBSRELA?

IBSRELA (tenapanor) is a prescription medicine used in adults to treat irritable bowel syndrome with constipation (IBS-C). It is not known if IBSRELA is safe and effective in children less than 18 years of age.

Please also see Medication Guide within the full Prescribing Information.

IMPORTANT RISK INFORMATION

  • Do not give IBSRELA to children who are less than 6 years of age. It may harm them.
  • You should not give IBSRELA to patients 6 years to less than 18 years of age. It may harm them. IBSRELA can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).
  • Do not take IBSRELA if a doctor has told you that you have a bowel blockage (intestinal obstruction).

Before you take IBSRELA, tell your doctor about your medical conditions, including if you are:

  • Pregnant or plan to become pregnant. It is not known if IBSRELA will harm your unborn baby.
  • Breastfeeding or plan to breastfeed. It is not known if IBSRELA passes into your breast milk. Talk with your doctor about the best way to feed your baby if you take IBSRELA.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.

Side Effects

Diarrhea is the most common side effect of IBSRELA, and it can sometimes be severe. Stop taking IBSRELA and call your doctor if you develop severe diarrhea.

Other common side effects of IBSRELA include swelling, or a feeling of fullness or pressure in your abdomen (distension), gas (flatulence), or dizziness.

These are not all the possible side effects of IBSRELA. Call your doctor for medical advice about side effects.

You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to www.fda.gov/medwatch.

What is IBSRELA?

IBSRELA (tenapanor) is a prescription medicine used in adults to treat irritable bowel syndrome with constipation (IBS-C). It is not known if IBSRELA is safe and effective in children less than 18 years of age.

Please also see Medication Guide within the full Prescribing Information.